Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chloe Shay

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|June 11, 2026
Glycolytic cancer-associated fibroblasts orchestrate metabolic remodeling in the tumor microenvironmentXinyu Cui, Akshaya Poonepalle, Chloe Shay, et al.
Advances in Experimental Medicine and Biology|March 29, 2019
PFKP Signaling at a Glance: An Emerging Mediator of Cancer Cell MetabolismLiwei Lang, Ron Chemmalakuzhy, Chloe Shay, et al.
Advances in Experimental Medicine and Biology|April 19, 2020
Targeting ROS-Mediated Crosstalk Between Autophagy and Apoptosis in CancerLixia Gao, Jenni Loveless, Chloe Shay, et al.
Experimental Hematology & Oncology|January 30, 2024
Cancer metabolism and carcinogenesisJianqiang Yang, Chloe Shay, Nabil F Saba, et al.
Journal of Hematology & Oncology|June 14, 2017
Augmentation of the anticancer activity of CYT997 in human prostate cancer by inhibiting Src activityYong Teng, Yafei Cai, Wenhu Pi, et al.
Cellular Oncology (Dordrecht, Netherlands)|October 7, 2017
Implications of FGF19 on sorafenib-mediated nitric oxide production in hepatocellular carcinoma cells - a short reportLixia Gao, Chloe Shay, Fenglin Lv, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 10, 2025
Tumor secretome shapes the immune landscape during cancer progressionJianqiang Yang, Sijia Tang, Nabil F Saba, et al.
Journal of Hematology & Oncology|December 7, 2019
Simultaneously inactivating Src and AKT by saracatinib/capivasertib co-delivery nanoparticles to improve the efficacy of anti-Src therapy in head and neck squamous cell carcinomaLiwei Lang, Chloe Shay, Xiangdong Zhao, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 20, 2019
Histone deacetylase inhibitors suppress aggressiveness of head and neck squamous cell carcinoma via histone acetylation-independent blockade of the EGFR-Arf1 axisLeilei He, Lixia Gao, Chloe Shay, et al.
Experimental Hematology & Oncology|June 14, 2026
Rewiring tumor metabolism: heterogeneity, oncometabolites, and adaptive plasticityJianqiang Yang, Catherine C Zhou, Soumya Vijaya Kumar, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Journal of Experimental & Clinical Cancer Research : CR|June 11, 2026
Glycolytic cancer-associated fibroblasts orchestrate metabolic remodeling in the tumor microenvironmentXinyu Cui, Akshaya Poonepalle, Chloe Shay, et al.
Advances in Experimental Medicine and Biology|March 29, 2019
PFKP Signaling at a Glance: An Emerging Mediator of Cancer Cell MetabolismLiwei Lang, Ron Chemmalakuzhy, Chloe Shay, et al.
Advances in Experimental Medicine and Biology|April 19, 2020
Targeting ROS-Mediated Crosstalk Between Autophagy and Apoptosis in CancerLixia Gao, Jenni Loveless, Chloe Shay, et al.
Experimental Hematology & Oncology|January 30, 2024
Cancer metabolism and carcinogenesisJianqiang Yang, Chloe Shay, Nabil F Saba, et al.
Journal of Hematology & Oncology|June 14, 2017
Augmentation of the anticancer activity of CYT997 in human prostate cancer by inhibiting Src activityYong Teng, Yafei Cai, Wenhu Pi, et al.
Cellular Oncology (Dordrecht, Netherlands)|October 7, 2017
Implications of FGF19 on sorafenib-mediated nitric oxide production in hepatocellular carcinoma cells - a short reportLixia Gao, Chloe Shay, Fenglin Lv, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 10, 2025
Tumor secretome shapes the immune landscape during cancer progressionJianqiang Yang, Sijia Tang, Nabil F Saba, et al.
Journal of Hematology & Oncology|December 7, 2019
Simultaneously inactivating Src and AKT by saracatinib/capivasertib co-delivery nanoparticles to improve the efficacy of anti-Src therapy in head and neck squamous cell carcinomaLiwei Lang, Chloe Shay, Xiangdong Zhao, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 20, 2019
Histone deacetylase inhibitors suppress aggressiveness of head and neck squamous cell carcinoma via histone acetylation-independent blockade of the EGFR-Arf1 axisLeilei He, Lixia Gao, Chloe Shay, et al.
Experimental Hematology & Oncology|June 14, 2026
Rewiring tumor metabolism: heterogeneity, oncometabolites, and adaptive plasticityJianqiang Yang, Catherine C Zhou, Soumya Vijaya Kumar, et al.
Pageof 4